ENYO Pharma featured in Biomim’BOOK 2021

Published on 07/05/2021

ENYO Pharma is featured in the 2021 edition of Biomim’BOOK, the first book dedicated to actors and stakeholders in Biomimetism and Bio-inspiration.
To see the full book: https://www.flickr.com/photos/biomimexpo/sets/72157718879047022/
To see ENYO Pharma double page: BIOMIM_BOOK 2021_ENYO PHARMA

Read next in 'Latest news'

• Orphan Drug Designation (ODD) granted to Vonafexor for Alport syndrome by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)
• New publication: Hepatic and renal improvements with FXR agonist Vonafexor in individuals with suspected fibrotic NASH
• New publication : An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
• Swiss NASH Foundation sponsorship
• ENYO Pharma in the Top 50 of the EIC ScalingUp List